Browsing Toxins By Category
Displaying toxin 1551 - 1575 of 3678 in total
| T3DB ID | Name CAS Number | Formula Weight | Structure | Type | Mechanism of Toxicity |
|---|---|---|---|---|---|
| T3D1846 | Fenpropathrin 39515-41-8 | C22H23NO3 349.423 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 32 |
| T3D1847 | Flucythrinate 70124-77-5 | C26H23F2NO4 451.462 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 20 |
| T3D1848 | Flumethrin 69770-45-2 | C28H22Cl2FNO3 510.384 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 19 |
| T3D1849 | Tau-fluvalinate 102851-06-9 | C26H22ClF3N2O3 502.913 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 20 |
| T3D1850 | Permethrin 52645-53-1 | C21H20Cl2O3 391.288 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 26 |
| T3D1851 | Tefluthrin 79538-32-2 | C17H14ClF7O2 418.734 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 29 |
| T3D1852 | Tralomethrin 66841-25-6 | C22H19Br4NO3 665.007 g/mol |  |
| Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase i...more Number of Targets: 20 |
| T3D1853 | Cinerin I 25402-06-6 | C20H28O3 316.435 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 20 |
| T3D1854 | Cinerin II 121-20-0 | C21H28O5 360.444 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 20 |
| T3D1855 | Jasmolin I 4466-14-2 | C21H30O3 330.461 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 20 |
| T3D1856 | Jasmolin II 1172-63-0 | C22H30O5 374.471 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 20 |
| T3D1857 | Pyrethrin I 121-21-1 | C21H28O3 328.445 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 20 |
| T3D1858 | Pyrethrin II 121-29-9 | C22H28O5 372.455 g/mol |  |
| Pyrethrins exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in...more Number of Targets: 21 |
| T3D1859 | Antimony monosulfide 12067-17-3 | HSSb 154.830 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1860 | Antimony tetramer 12597-17-0 | Sb4 487.040 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1861 | Antimony(III) isopropoxide 18770-47-3 | C9H21O3Sb 299.020 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1862 | Antimony(III) ethoxide 10433-06-4 | C6H15O3Sb 256.940 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1863 | Chlorofluorotrimethylantimony 13077-54-8 | C3H9ClFSb 221.310 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1864 | Chlorohydroxytriphenylantimony 36368-97-5 | C18H16ClOSb 405.530 g/mol |  |
| The inhalation data suggest that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes ...more Number of Targets: 20 |
| T3D1866 | Diantimony diselenide 193095-46-4 | Sb2Se2 401.440 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |
| T3D1867 | Diantimony tetrasulfide 12359-48-7 | S4Sb2 371.780 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |
| T3D1868 | Dibromotributylantimony 16629-56-4 | C12H27Br2Sb 452.910 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |
| T3D1869 | Dichlorotribenzylantimony 19493-17-5 | C21H21Cl2Sb 466.060 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |
| T3D1870 | Dioxygenyl hexafluoroantimonate 12361-66-9 | F6O2Sb 267.750 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |
| T3D1872 | Hexafluoroantimonic acid 16950-06-4 | F6HSb 236.760 g/mol |  |
| The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes...more Number of Targets: 20 |